Transparent GLP-1 Care, From Evaluation to Follow-Up
GLP-1 treatment plans designed around your medical history, goals, and ongoing progress
Check your eligibility
Complete a quick online assessment. A licensed provider determines eligibility.
Get prescribed
If approved, your medication is shipped directly from a U.S. pharmacy.
Begin Your Provider-Directed Care Plan
Follow your personalized plan with ongoing medical and coaching support.
What your personalized plan includes
|
|
Other Competitors | |
|---|---|---|
|
Same price at every dose. No memberships or contracts.
|
Included
|
May increase or include extra fees
|
|
Fast, free shipping, designed to help avoid skipping doses.
|
Included
|
Speed and cost vary
|
|
Provider review + medical guidance included
|
Included
|
Short-term, meds-only
|
|
Clinical check-in available when needed
|
Included
|
Limited hours or automated
|
|
Free nutrition plan + 1:1 fitness call
|
Included
|
Community not included
|
|
Ongoing provider access throughout treatment
|
Included
|
Varies by provider
|
Medication made affordable
Check your BMI
Enter your height and weight below
3 Simple steps to a better you
Submit your application
and meet with a doctor
Get your medication
delivered at home
Receive 24/7 support
and ongoing care
We Stand Behind Our Program
Provider-guided support throughout your weight-management journey.
Semaglutide and tirzepatide act on gut hormone pathways involved in appetite regulation and gastric emptying. Your provider determines whether treatment is clinically appropriate for you.
Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain. Serious risks include thyroid C-cell tumors, pancreatitis, and gallbladder disease. See Important Safety Information.
Do not use if you or a family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Tell your provider about all medical conditions and medications.
Results vary by individual and depend on adherence, diet, activity, and provider guidance. Compounded medications are not FDA-approved and have not been evaluated for effectiveness.
A Medical Team Built Around Your Progress
Am I eligible?
Most adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol, may be candidates. Complete a short online assessment and a U.S.-licensed provider will review your health history before determining whether treatment is clinically appropriate. Not everyone who completes an assessment will be prescribed treatment.
How much does compounded tirzepatide cost?
NexLife offers compounded tirzepatide starting at $169/month with no hidden fees. Multi-month plans reduce the cost further: $159/month (3-month plan), $149/month (6-month plan), and $139/month (12-month plan). All plans include free expedited shipping, provider consultations, a personalized nutrition plan, and a 1:1 fitness coaching call. FSA and HSA payments are accepted. Financing is available through Klarna and Affirm.
How does tirzepatide work for weight management?
Tirzepatide is a dual GLP-1 and GIP receptor agonist. It acts on two hormone pathways involved in appetite regulation and gastric emptying. Whether it is appropriate for you is determined by a licensed provider based on your medical history. Compounded tirzepatide is not FDA-approved and has not been evaluated for effectiveness.
What is compounded tirzepatide?
Compounded tirzepatide is prepared by a U.S.-licensed compounding pharmacy pursuant to a prescription, in accordance with applicable federal and state requirements. A provider may prescribe it when they determine it is clinically appropriate following an individual evaluation. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Compounded tirzepatide is not Mounjaro® or Zepbound®.
What is the difference between tirzepatide and semaglutide?
Semaglutide is a GLP-1 receptor agonist and acts on one hormone pathway. Tirzepatide is a dual GLP-1 and GIP receptor agonist and acts on two. Both are prescribed once weekly by subcutaneous injection. Which option is appropriate for you, if either, is a decision for your provider based on your medical history, other medications, and clinical profile. Compounded semaglutide starts at $139/month and compounded tirzepatide at $169/month. Neither compounded product is FDA-approved or has been evaluated for effectiveness.
How soon will I see results?
Results vary considerably from person to person and depend on adherence, diet, activity, dose, and individual factors. No specific result or timeline is guaranteed, and compounded medications have not been evaluated by the FDA for effectiveness. Your provider can discuss what to expect based on your circumstances.
Is this safe?
Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. That means less is known about them than about approved medicines.
GLP-1 medications carry serious risks, including a boxed warning for thyroid C-cell tumors. Do not use if you or a family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Other serious risks include pancreatitis, gallbladder disease, kidney injury, and low blood sugar. Common side effects include nausea, vomiting, diarrhea, and constipation.
Whether treatment is appropriate for you depends on your medical history, and only a licensed provider can make that determination. Read the full Important Safety Information before starting, and discuss any concerns with your provider.
What are the most common side effects?
The most common side effects of tirzepatide include nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, fatigue, and injection-site reactions, particularly during the first weeks and after a dose increase.
Serious risks include thyroid C-cell tumors, pancreatitis, gallbladder disease, kidney injury, low blood sugar, and severe allergic reactions. Do not use if you or a family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
Providers typically start at a lower dose and increase gradually. Report any side effect to your provider. Read the full Important Safety Information before starting treatment.
What happens after I complete the quiz?
A licensed provider reviews your responses and health history and determines whether treatment is clinically appropriate. Not everyone is approved. If a prescription is issued, it is sent to a U.S.-licensed compounding pharmacy and shipped to your address. Delivery times vary by pharmacy processing and location.
How is NexLife different from other GLP-1 providers?
NexLife includes $377 in added value at no extra cost with every plan: a personalized GLP-1-focused nutrition plan ($99 value), a 1:1 fitness coaching call with a certified wellness coach ($79 value), and provider review with medical guidance ($199 value). NexLife also offers a money-back warranty — follow the plan and lose up to 10% of your body weight in 6 months, or get your money back. The same price applies at every dose with no price increases as you titrate up. NexLife is LegitScript-certified and works only with LegitScript-certified, NABP-accredited compounding pharmacies.
Do I need to see a doctor in person?
No in-person visit is required. Your evaluation and ongoing care are conducted online. A U.S.-licensed provider reviews your health information, determines whether treatment is appropriate, and monitors your progress remotely. Your care may be delivered by live video or by provider review of the information you submit, depending on your state and your provider's clinical judgment.
How does shipping work?
Once a provider approves treatment, your medication is prepared by a U.S.-licensed compounding pharmacy and shipped to your home. Delivery times vary by pharmacy processing, your location, and applicable law. Shipments are discreetly packaged.
What kind of support do I receive?
Every NexLife member receives access to licensed provider oversight, a personalized nutrition plan, a 1:1 fitness coaching call, and 24/7 support through the Care 360 system. Your care team includes board-certified physicians, registered dietitians, and dedicated care coordinators who specialize in metabolic health and long-term clinical care.
Can I cancel or adjust my plan?
Yes. NexLife plans are offered as a subscription and may be canceled at any time. Your provider can also adjust your dosing or treatment plan based on your progress. Contact your care team or manage changes through your account dashboard.
Why Nexlife?
Book a FREE 20-minute consultation with a Provider before you start with NexLife
IMPORTANT SAFETY INFORMATION & DISCLOSURES
About Nexlife. Nexlife is a telehealth and care-coordination platform. Nexlife does not practice medicine, and does not manufacture, compound, test, label, or dispense any medication. Completing an online assessment does not create a provider–patient relationship; that relationship is formed only on clinical review and acceptance by a licensed provider. Providers exercise independent medical judgment and may prescribe, adjust, pause, or decline treatment based on clinical appropriateness, your medical history, contraindications, and applicable state law.
Pharmacy fulfillment. Prescriptions are fulfilled by Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL), and Boudreaux's New Drug Store (Lake Charles, LA), each licensed in the United States and operating under state board oversight and applicable sterile compounding standards. Fulfillment may vary by patient location, provider direction, pharmacy availability, and applicable law. Product appearance, concentration, packaging, and labeling may vary by pharmacy and state, and may differ from images shown on this website.
Service availability. Nexlife services are available only to individuals physically located in U.S. states where affiliated providers are licensed and pharmacy fulfillment is permitted. Individual results vary. Nexlife does not guarantee weight loss, treatment success, clinical outcomes, prescription approval, medication eligibility, pharmacy availability, or delivery timelines. Service availability, medication access, pharmacy options, formulations, pricing, and platform features may change.
GLP-1 medications of this class caused thyroid C-cell tumors in rodents. It is not known whether they cause these tumors in humans. Do not use compounded semaglutide or compounded tirzepatide if you or a family member has had medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Do not use if you have had a serious allergic reaction to semaglutide or tirzepatide. Tell your provider right away about a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.
Serious risks include inflammation of the pancreas (pancreatitis), gallbladder disease and gallstones, kidney injury from persistent vomiting or diarrhea, low blood sugar (particularly with insulin or a sulfonylurea), slowed stomach emptying, worsening of diabetic retinopathy, and sudden vision loss from non-arteritic anterior ischemic optic neuropathy (NAION). Contact your provider immediately for severe abdominal pain, persistent vomiting, or any change in vision. Tell your provider about any new or worsening changes in mood, behavior, or thoughts.
Before any surgery or procedure involving anesthesia or deep sedation — including endoscopy, colonoscopy, and dental sedation — tell your surgeon and anesthesiologist that you take a GLP-1 medication. These medications slow stomach emptying, and food may remain in the stomach after standard fasting, increasing the risk of aspiration.
Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding. These medications should not be used during pregnancy. Also tell your provider about all medications, vitamins, and supplements you take, including insulin and sulfonylureas. If you use oral hormonal birth control, tirzepatide may reduce its effectiveness; ask your provider about switching to a non-oral method or adding a barrier method for 4 weeks after starting and after each dose increase.
Dosing. Compounded GLP-1 medications are typically dispensed as subcutaneous injections in multi-dose vials, with dosing, titration, concentration, and formulation determined by the prescribing provider.Follow only the dosing instructions provided for your specific prescription. Medication concentration and syringe markings vary by pharmacy and formulation. Do not independently convert between milligrams, milliliters, and syringe units. If the vial label, prescription instructions, and syringe markings do not agree, do not inject; contact your provider or dispensing pharmacy.Measuring a dose in insulin units can result in a tenfold overdose. Follow the written instructions supplied with your medication exactly. If those instructions, the vial label, and what you were told do not agree, do not inject — contact your provider or the dispensing pharmacy. Never share needles or syringes with anyone. Some formulations may include additional ingredients such as methylcobalamin (Vitamin B12), glycine, or pyridoxine (Vitamin B6). Ask your pharmacy what your specific formulation contains.
Common side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, indigestion, headache, fatigue, and injection-site reactions. Stopping treatment may lead to weight regain.
This is not a complete list of risks. Read the full Important Safety Information and discuss any questions with your provider. Report side effects to your provider, to the dispensing pharmacy, and to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. For a medical emergency, call 911. Withholding or providing inaccurate information about your health and medical history in order to obtain treatment may result in harm, including, in some cases, death.
Compounded medications are not FDA-approved and have not been evaluated by the U.S. Food and Drug Administration for safety, effectiveness, or quality. Compounded semaglutide is not Ozempic® or Wegovy®, and compounded tirzepatide is not Mounjaro® or Zepbound®. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S; Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Nexlife is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly. FDA-approved alternatives exist — ask your provider about them.


